Applied Genetic Technologies reported $-13102000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Alimera Sciences ALIM:US $ -1.27M 2.19M
Applied Genetic Technologies AGTC:US $ -13.1M 4.79M
Avrobio Inc AVRO:US $ -27420000 1.6M
Biogen BIIB:US $ 1075.7M 401M
Bluebird Bio BLUE:US $ -99.42M 19.92M
Celldex Therapeutics CLDX:US $ -20.66M 1.79M
Gilead Sciences GILD:US $ 2585M 837M
Insmed INSM:US $ -98081000 92K
Intercept Pharmaceuticals ICPT:US $ -10.87M 0.98M
Life Technologies LIFE:US $ -12.3M 3.76M
Ophthotech OPHT:US $ -49.73M 15.08M
Regeneron Pharmaceuticals REGN:US $ 1381.3M 20.4M
Ultragenyx Pharmaceutical RARE:US $ -137.11M 4.57M